Pictet Asset Management (UK)’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$289K Sell
3,156
-344
-10% -$27.3K ﹤0.01% 1437
2021
Q1
$238K Sell
3,500
-1,200
-26% -$93.2K ﹤0.01% 1577
2020
Q4
$341K Buy
+4,700
New +$272K ﹤0.01% 1321

Other funds holding CDNA

Pictet Asset Management (UK)'s CDNA Position: Q2 2021 in Review

Pictet Asset Management (UK) reduced its CareDx (CDNA) stake by 9.8% in Q2 2021, selling an estimated $27.3K and leaving 3,156 shares worth $289K. The position accounts for ﹤0.01% of the portfolio, ranked #1437.

Pictet Asset Management (UK) first reported a position in CDNA in Q4 2020 and has held it in 3 quarters since. The position peaked at $341K in Q4 2020. 254 funds tracked by Wall St. Rank hold CDNA as of Q2 2021.

  • Pictet Asset Management (UK) held 3,156 shares of CareDx worth $289K as of Q2 2021.
  • Pictet Asset Management (UK) sold 344 CareDx shares in Q2 2021, an estimated $27.3K.
  • CareDx made up ﹤0.01% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #1437 holding.
  • Pictet Asset Management (UK) first reported a position in CareDx in Q4 2020 and has held it in 3 quarters since.
  • Pictet Asset Management (UK)'s CareDx position peaked at $341K in Q4 2020.
  • 254 funds tracked by Wall St. Rank held CareDx as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.